We have developed a proprietary 3D Bioprinted hydrogel matrix which is the only expandable culture substrate able to by-pass the need to sub-culture. Our T-Blocks increase cell production by 3,600X compared against traditional cell culture methods and reduce consumable costs by 93% and reduce labor and handling time by 97%, to help researchers meet increasing demand for cell culture-based vaccines.
Ronawk’s Bio-OS is a defensible biodiscovery and biomanufacturing platform that has been proven to work with many cell types, it improves timeline from discovery-to-market, with better quality and substantial economic advantages. Ronawk addresses a foundational infrastructure gap in biotechnology. By aligning tools with the realities of human biology, Bio-OS reduces biological drift, improves reproducibility, and preserves functional integrity as systems scale. This approach shortens development timelines, lowers technical risk, and increases the probability that promising therapies advance from discovery to manufacturing.
Ronawk was built not simply to improve existing workflows, but to re-architect how biology is handled across the life sciences. By combining disciplined engineering with a clear long-term vision, the Company is creating durable biological infrastructure that supports next generation therapies, data driven discovery, and scalable biomanufacturing.
